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Abstract: There are over 2.6 million users of e-cigarettes in the United Kingdom alone.  
E-cigarettes have been promoted as safer alternative to traditional cigarettes. The 
addition of flavours and aromas have also proven to be popular with younger 
generations. In this communication we investigated the composition of the e-cigarette 
refills and assessed the biological effect of e-cigarettes refills on Beas2B (epithelium 
cells). We established that e-cigarette refills are complex mixtures of solvent vehicle, 
flavours with or without nicotine and their components are toxic towards the cells.  
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 Background 
Electronic cigarettes (e-cigarettes, e-cig or personal vaporisers (PV) are battery-
powered devices that deliver vaporised chemicals to the user, current sales are over 
$1.7 billion for 2013 (Orellana), while there are over 7500 flavour variations at the 
moment (Sherwood). They may contain nicotine alongside other chemicals, such as 
flavourings and enhancers, while some variants may contain tobacco extracts1. The 
key differences between conventional and e-cigarettes are that e-cigarettes do not 
usually contain tobacco2.  Smoking conventional cigarettes leads to the combustion of 
tobacco products. The process of heating in e-cigarettes is gentler than in conventional 
cigarettes2. Several studies clearly show that e-cigarettes vapours have less 
combustion products than the ones produced by regular cigarettes, many of which 
originating from regular cigarettes are carcinogenic2, New manufacturers are 
increasing the heating temperature in e-cigarettes to allow for a more “real” effect. As 
30% of the cancer deaths in USA are caused by tobacco, more precisely from the tar 
component which is the killer (Hartung short), it is understandable that e-cigarettes 
(with no tar) are being branded a safer alternative to tobacco. 
E-cigarettes are composed of a cartridge or tank which is used to store liquid material 
containing the “e-liquid”, “e-juice” or “nicotine solution”11. The cartridge serves as a 
reservoir of storage for the liquid and also acts as the mouthpiece of the e-cigarette. A 
heating element is used as an atomiser to turn the liquid into a vapour10, and a power 
source such as a battery, which can be either manual or automatic, make up the rest 
of the device. The vapour is only produced while the heating element is activated and 
not between puffs. The vaporised liquid condenses into an aerosol, later inhaled to 
deliver nicotine and flavourings11,12. The vapour is generated by heating the solution 
to temperatures ranging from 65°C to 120°C, with a reported maximum atomiser 
temperature of approximately 250°C11.  This can increase the chances of carbonyl 
formation. Different models are available with some more manual to control the 
delivery and temperature (Breland). Propylene glycol and glycerine are used as 
carriers with the first one being the more widely employed, even though glycerine has 
been used in traditional cigarettes (Carmines). The vapour can contain carbonyl 
compounds like formaldehyde, acetaldehyde, and acrolein, which have been shown in 
numerous studies to be toxic. Formaldehyde and acetaldehyde are classified as 
carcinogens13,14 and acrolein as an irritant15. 
E-cigarettes are sold as a healthier option to tobacco smoke and physicians are 
currently asked about their opinions in this area (Arnold).  Furthermore, around 95% 
of the general population believe them to be healthier than conventional cigarettes 
(Kaisar). So far the research has proven that the e-cigarette vapour is not benign, but 
less hazardous than traditional cigarettes (Arnold). E-cigarette users commented on 
open forums on the internet about side effects such as headaches, respiratory tract 
irritations and digestive problems (Arnold). Clinical studies has shown that only 10% 
of traditional smokers quit smoking after switching to e-cigarettes.  The biggest change 
observed was in the reduction of traditional cigarettes per day in favour of e-cigarette 
puffing (Kaisar). On the pro e-cigarette side, the absence of the tar products, pyrolysis 
and lower plasma nicotine content (around 10% that of the tobacco cigarette) would 
make it a healthier option for traditional cigarette smokers.  A clinical study has also 
shown that cell blood counts and markers are statistically not affected by exposure to 
e-cigarette users and passive user.  On the contrary, the exposure to tobacco 
cigarettes (users and passive users) showed an indication of inflammation after 3 
hours (Flouris). 
However, there is conflicting information regarding the risks posed to public health and 
the health benefit from e-cigarettes. The Consumer Advocates for Smoke-free 
Alternatives Association (CASAA), has reported a significant risk reduction when 
assessed against regular cigarettes4. However, various studies indicate that e-
cigarettes may produce long-term and short-term side effects, such as airway 
resistance, irritation of the airways, redness of the eyes and drying out the throat6-8. 
Research has been focused on the toxicological effects of e-cigarettes on lung, heart 
and cancer (Orellana).  While some reports might have inconsistencies or conflict of 
interest.  The general view indicates a toxic effect (McKee). The World Health 
Organisation (WHO) and the Food and Drug Administration (FDA), have indicated that 
the safety and the potential health damage of e-cigarettes and its constituents have 
not been fully studied and so remain undetermined9,10. Guidelines form the FDA 
indicate an inclination towards the enforcement if the same rules applying to traditional 
cigarettes for the term of sales and marketing strategies of electronic cigarettes 
(Orellana). 
The majority of research to date has been divided between: i) analytical assessment 
of the e-liquids, ii) analytical assessment of the vapour phase, iii) toxicity of the e-liquids 
and/or vapour in animal models and/or animal cells, iv) toxicity of the e-liquids and/or 
vapour in human cells (primary and immortalised both cancer and non-cancerous, 2-
dimension and 3-dimension) and v) clinical studies on cigarette (traditional and/or e-
cigarettes) smokers. Though the analytical assessment seems to be more reproducible 
due to standardised methods used in the chromatographic method, eluents, and 
detection, more variability appears in the biological work.  This might be related to the 
dosing, concentration of ingredients, sample variation from same or different 
manufacturers, flavourings, cells and even the media. 
Composition 
Tobacco smoke comprises many classes of chemicals including polycyclic aromatic 
hydrocarbons, benzo(a)pyrenes, and tobacco specific nitrosamines such as 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), and N'-nitrosonornicotine 
(NNN)3. E-cigarettes do not have a source of combustion, and this is a reason why the 
health risks of vaping are assumed to be less harmful compared with traditional 
smoking. Therefore manufacturers have shown a growing interest to produce e-
cigarettes, for indoor use, whereas the traditional cigarettes have been banned4,5. 
Nevertheless, the components in the e-cigarette aerosol and e-liquid refills contain the 
carbonyls formaldehyde (up to 9.0 µg/g of e-liq), acetaldehyde (up to 10.2 µg/g of e-
liq), acrolein (up to 5.5 µg/puff), propionaldehyde (up to 1500 ng/puff), as well as the 
Volatile Organic Compounds (VOCs) toluene (up to 6.3 µg/150 puff), N-
nitrosonornicotine (NNN) (up to 16.7ng/mL e-liq), 4-(methylnitrosamino)-1-(3-pyridyl)-
1-butanone (NNK) (up tp 10.8ng/mL e-liq), glycols such as propyelene glycol and 
glycerine (variation), nicotine (depending on the manufacturer’s label), traces of 
polycyclic aromatic hydrocarbons and the metals Ni (up to 0.29 µg/150 puff), Cd (up to 
0.22 µg/150 puff) and Pb (up to 0.57 µg/150 puff) with traces of Ag, Al, Zn and Cr 
(Kaiser, PisingersNumbers for reference?). 
Nicotine. From vapours containing tobacco, tobacco specific nitrosamines (TSNAs) 
including N’-nitrosonornicotine (NNN) and 4-(methylonitrosoamino)-1-(3-pirydyl)-l-
butanone (NNK) can be formed in the combustion process in traditional cigarettes 
(Callahan) and are considered to be highly toxic17,18. There is evidence that these toxic 
carbonyl compounds have been found in the vapour of e-cigarettes (Besaratinia 
Number?). Some studies have demonstrated that impurities and nicotine degradation 
products such as nicotine-cis-N-oxide, nicotine-trans-N-oxide, myosmine, anabasine, 
and anatabine, which are very carcinogenic, can be found in e-cigarettes refill liquids20. 
The molecules can lead to mutations in genes such as Ras (vital function in signal 
transduction of cell proliferation), p53 and Retinoblastoma (with roles as tumour 
suppressors) as these molecules can form adducts with cellular DNA21-24. Nicotine can 
be absorbed through different routes such as inhalation, ingestion, skin, and mucous 
membranes.  Therefore it is feasible that the vapour from e-cigarettes users could 
cause secondary exposure of nicotine and other toxins to the individuals in the 
surrounded area3. Nicotine is a stimulant and side effects can include death.   
 
A danger of e-cigarette refills are for those bottles containing fruity or sweet flavours 
and aromas which children can mistake for fruit juices.  A fatality has been reported of 
a 2 year old child after drinking an unknown amount of e-cigarette refill (Breland). 
Concentrations of nicotine in the air have been studied for conventional and e-
cigarettes.  It has been reported that e-cigarettes with a refill liquid of nicotine 
concentration of 24 mg/ml emitted nicotine concentrations between 0.82 μg/m3 to 6.23 
μg/m3, with the mean concentration of nicotine from regular cigarettes ten times higher 
(31.60 ± 6.91 μg/m3)25. A threshold limit of nicotine exposure in the work place is 
published by The American Conference of Governmental Industrial Hygienists and is 
established for an eight-hour time-weighted average (TWA), as 500 μg/m3 26. 
Manufacturers normally indicate the expected level of nicotine in the e-cigarette refills.  
Though they are often very close to the label value, some samples seem to not reflect 
the label value (Callahan). We observed in our studies that the origin of nicotine is also 
an important factor.  Nicotine can be used in the chemical industry, and this grade of 
nicotine is not as pure as pharmaceutical nicotine which should be employed in the 
tobacco industry. 
Alkaloids are present in plants and one of the most notorious examples is nicotine.  
Other alkaloids from tobacco can include cotinine, myosmine and anabasine, with most 
of them being present in e-cigarette refills. A comprehensive study on the alteration of 
gene expression on CCL-185 (human lung carcinoma cell line) upon exposure to these 
four alkaloids (Marlowe) showed an increase of CEACAM6 (an adhesion molecule 
involved in carcinogenesis and metastasis) when the cells were treated with nicotine 
and myosmine, and a decrease when exposed to anabasine and cotinine. In the case 
of ALDH3A1 (an enzyme involved in the detoxification of reactive aldehydes), the 
treatment with myosmine showed an increase, while for PIR (transcription regulator for 
apoptosis and oxidative stress) a decrease was observed in the cases of nicotine, 
anabasine and cotinine.  Mysomine had little effect on PIR. Only nicotine showed an 
increase of TLR4 (a ligand involved in the immune response) while the other 
compounds showed a decrease thereof (Marlowe). 
. 
Various metals such as nickel, cadmium, lead and silica particles can be present in the 
aerosols produced from e-cigarettes.  They could arise from the wick and heating coil 
constituents.  These metals are considered to be carcinogenic, nephrotoxic, 
neurotoxic, and hemotoxic19.  
 
Glycerine (glycerol) and propylene glycol. Glycerine, also called glycerol, is an 
intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, 
pharmaceutical, and sweetening agent in food industry27. Both glycol and glycerine are 
used in manufacturing industries, as well as aviation and are well knowns respiratory 
irritants (Callahan Lyon). Glycerine and propylene glycol are chemical compounds both 
used in normal and e-cigarette liquids to control the moisture content28. However, they 
may be pyrolysed (burned) to acrolein and formaldehyde at higher temperatures14. 
Acrolein and formaldehyde have been found in e-cigarette vapour even though the 
levels detected were 15 times smaller than in conventional cigarettes. This is due to 
the fact that the evaporation temperature of e-liquids at 60oC-120oC is lower than that 
of the combustion temperature of up to 650oC in regular tobacco cigarettes29.  
 
Flavourings and their toxicities. The sensation of flavours is determined by chemical 
substances that can interact with the senses of taste and smell30. There are over 2500 
flavouring substances being employed in the food industry.  Safety procedures have 
been introduced to control their use (Munro), though they are directed to consumption 
of food rather than e-cigarettes, where the uptake is different. In general, oral 
consumption, and the quantities in the food need to be considered. These 
chemicals/flavouring substances (aldehydes, esters, acids) tend to be metabolised 
very rapidly through active enzymes in the liver and intestine (Phase I and Phase II 
enzymes, including the CYP450 family and glutathione transferase) (Munro).  A 
decision tree is followed based on the chemical structure and is based on data from 
human and animal studies. The Flavour and Extract Manufacturers Association 
(FEMA) assess the safety of chemical compounds used as flavouring ingredients, but 
cannot regulate the use the flavour ingredients in e-cigarettes, because the use of the 
flavourings in e-cigarettes has not been approved31. Adding flavours to traditional 
cigarettes has been practised in some countries. Some anti-tobacco groups claimed 
this could attract new smokers.  Different flavours can be added from oils to natural 
extracts, with the majority of them in the fruity range, such as mint and menthol.  In the 
case of traditional cigarettes, the combustion temperature could produce pyrolysis or 
oxidation of these compounds and convert them into toxic carbonyls (Baker). There is 
often no more information given about the composition or source of such additives, 
other than that these flavours are “natural“4. As the most widely available sources of 
flavourings are for food products, we could expect some of the e-cigarette 
manufacturers could be using food flavouring products. For example, diacetyl 
(butanedione or butane-2,3-dione) is a by-product of the transformation of glucose to 
ethanol by yeast during the beer fermentation process and is extensively used in the 
food industry  to flavour dairy products (batarfi).  It is safe as food flavouring in popcorn, 
but when inhaled it has been shown to produce “popcorn lung syndrome” or 
bronchiolitis obiliterans32. Animal studies of diacetyl exposure has shown 
morphological changes in the liver (Batarfi).  Studies of cells exposed to butterscotch 
flavoured e-cigarettes have also shown toxicity33.  
Menthol is one of the most widely used flavours in both e-cigarettes and traditional 
cigarettes.  These mentholated (e)-cigarettes seem to mask some early signs of 
respiratory diseases as menthol has antitussive properties.  Nevertheless, this seems 
to be more a hypothesis than being backed by real data (Heck) and very limited 
information of toxicological data is available even on traditional cigarettes (Wang). 
Menthol is a volatile compound and it could be ready vapourised rather than suffer 
pyrolysis. As a food additive, menthol has been subjected to many toxicological 
research, but little has been done on the respiratory tract with very little findings 
besides irritation in viv. Nevertheless, menthol is present in many products directed to 
treat respiratory problems such as the case of Vicks Vaporub.  
An interesting study (MRVA) on an adenocarcinomic human alveolar basal epithelial 
cell (A549) showed that exposure to vapours of several flavouring agents, e.g 
cinnamladehyde, benzaldehyde, diacetyl, 2,3-pentadione, vanillin, acetoin and 
triacetin, for 24 hours, proved to be very toxic to the cells.  This was especially the case 
for cinnamaldehyde and benzaldehyde. This is in accordance with other studies in 
which cinnamon flavour in e-liquids has shown high cytotoxicity levels in other cells34. 
Interestingly, vanillin, acetoin and triacetin proved to be the less toxic. Another study 
employing the same cell line, but different varieties of e-liquids, found no toxicity though 
there was an increased level on the release of IL-8 (Misra) at a very high dose.  
A549 is a cancer cell line, generally used for anticancer drug screening and safety 
profiling of new drugs. Immortalisation of human cells using telomerase or SV40 virus 
are good options for cytotoxic studies.  In the case of bronchial cells, some examples 
are Beas-2B and 16-HBE14o. A study testing individual flavours for chocolate (2,5-
dimethypyrazine), vanillin, apple/citrus (damascenone), floral (linalool), raspberry (α-
ionone), caramel (ethyl maltol) and strawberry furaneol challenged the cells for 24 
hours. At the concentrations tested findings shown vanillin and furaneol were relatively 
non-toxic (in agreement with other studies of vanillin). The rest of the flavours showed 
activity on the cells, with the chocolate flavour showing a reduction of the capability of 
producing/communicating signalling molecules (Sherwood). 
As the e-cigarette industry is growing, more needs to be done to assess the quality of 
the ingredients as well as the biological effects thereof. Some groups compared both 
the analytical composition and the toxicological effect of the e-liquid and the vapours 
associated with it (Costigan, Kosmider). The different temperatures that can be 
achieved in the vapourisation chamber (up to 350°C), can modify the functionality of 
the chemical ingredients and transform them into dangerous carbonyls such as 
formaldehyde and acetaldehyde.  The concentration in the vapour seems to be 
dependent on the voltage and temperature (Kosmider).  The amount of nicotine found 
in the aerosol has been found to be 85% lower than traditional cigarettes (Tayyarah), 
which implies that the smoker and passive smokers of e-cigarettes are exposed to less 
damage.  
A very interesting decision tree for carcinogenicity, mutagenicity and teratogenicity for 
flavourings proposed by Costigan (Costigan) highlights the need to compare both what 
the seller informs the buyer about the ingredients and their quantities with the results 
from the e-liquid and breakdown products employing GC-MS. From here the 
ingredients can be compared to existing data bases for biological information.  If more 
and/or new ingredients are found, then they will need to be assessed. 
Analytical method of assessment 
Gas-chromatography coupled to mass spectrometry, GC-MS, is the most popular 
method for analytical detection in majority of the articles published. Other variants 
include gas chromatography coupled to thermal energy analysis (GC-TEA) which is 
very sensitive to nitrosamines (Tuyyarah) and liquid chromatography with tandem 
mass spectrometry (LC-MSMS). Each technique has benefits and disadvantages. The 
ingredients in the e-liquids are volatile compounds, and some e-liquids have a simple 
formulation (single flavouring agents, propylene glycol, nicotine), while others have 
complex mixtures (natural extracts for flavour, sweeteners, tobacco and more)ref. GC 
relies on the volatility of each chemical and when this is not possible a process of 
derivatisation can be used. LC on the other hand, does not require the compounds to 
be volatile but to dissolve in the elution system, generally using acidified (0.1% formic 
acid) water/methanol or water/acetonitrile. Columns used in both methods are 
generally based on carbon 18.  In the case of LC, polar columns such as HILIC have 
been very useful. We have found that some compounds, such as menthol, are not 
detected very well in LC-MS though it is easily observed when using GCMS. The 
tandem quadruple MSMS or time of flight ToF allows for quantification if a patron was 
used for compound monitoring (optimisation technique that works as a fingerprint). 
Limits of detection and sensitivity apply to all techniques as well as accuracy 
(Tayyarah). Some groups have used both GC-MS and LC-MS but for different 
purposes (Kavvalakis). For example, GC-MS were used for the analysis of 
solvents/humectants (propylene glycol and glycerine) and polycyclic aromatic 
hydrocarbons, while LC-MS were employed for the quantification of nicotine, 
nitrosamines and flavours. 
From the review data, there is no “one fits all” analysis technique, but more modern 
equipment seem to perform better than some of the older techniques. Infra-red (IR) 
technology can detect the functional groups in small molecules, and can differentiate 
if there is a carbonyl in a sample, a hydroxyl or a nitrile group. New and more sensitive 
equipment using IR is emerging and allowing analysis of materials used in the 
cosmetic, food, and forensic industries (Deconinck ALL). Techniques like Attenuated 
Total Reflectance – Fourier Transform – IR (ATR-FT-IR) and near IR (NIR) alongside 
modelling methods  like K-nearest neighbours (k-NN), partial least squares-
discriminant analysis (PLS-DA), software independent modelling by class analogy 
(SIMCA), classification and regression tress (CART) and randon forests with Matlab 
as data processing software have been widely used to determine if an e-liquid has 
nicotine or not (Deconinck). 
Heating propylene glycol can produced the toxic carbonyls formaldehyde (600°C), 
acetaldehyde (600°C),  and acrolein (traces at 350°C) (Uchiyama).  A free-radical 
dehydration of glycerol yields 3-hydroxyl-1-propen-1-ol and through tautomerisation 3-
hydroxylpropionaldehyde can be obtained.  The latter one can lose one water molecule 
through free-radical formation to give rise to acrolein (Gillman). If the temperature is 
>400°C, 3-hydroxylpropionaldehyde can be converted to formaldehyde and 
acetaldehyde by a retro-Aldol reaction (Gillman). An interesting study (Gillman) 
trapped aerosols at different vapour conditions and monitored the formation of 
aldehyde by means of trapping with 2,4-dinitrophenylhydrazine and assessing it by 
HPLC-UV. The coil in the electronic compartment will heat the e-liquid when power is 
applied, and this is measure in watts. It is noticeable that different electronic designs 
produce a different output. While some designs produce a steady increase in the three 
aldehydes when more power (producing more temperature) is applied, in some other 
cases the amount remains at low levels and with no increase. 
Metal content is a known issue in traditional cigarettes and traces of metals have been 
found in e-cigarettes, ICP-MS methods have also been used to assess the heavy metal 
content in e-liquids (Beauval). 
Health 
E-cigarettes are getting more widely used due to promotion by manufacturers as a 
healthier alternative to conventional smoking. Amongst the complaints e-cigarette 
users describe, mouth and throat irritations have a high incidence.  This could be due 
to carbonyls formed during vaping15. It is important to notice that burns are also 
important consequences from the electronic devices due to faulty or fake batteries 
and/or mechanisms (monks).  
Other volatile organic compounds (VOCs) such as toluene and m,p-xylene which can 
be produced in the process are considered to be carcinogenic, hemotoxic, neurotoxic 
and irritants16. More harmful side effects are continuously being found35-40 through in 
vitro and animal models. The vapour heating process can produce carbonyls, though 
not in as high concentrations as traditional smoking.  There is biological evidence that 
aldehydes are toxic to mammalian cells by acting as mutagens, producing DNA single-
strand breaks and chromosomal aberrations (Golzer). Toxicity comes in different 
shades, and in the case of human and animal subjects, toxicological studies imply the 
assessment of biomarkers such as pro-inflammatory cytokines, development of 
cancer, teratogenicity, plasma nicotine concentration and effect on metabolism (Golli).  
For animal models a lethal dose can be easily assessed. In the case of cell culture, 
toxicity initially appears as cell viability, followed by cell health, metabolic pathways, 
mutagenicity, release of cytokines and signalling (golli). Studies in mice, which are 
indicators of acute exposure due to high concentrations and short, but persistent 
contact with the vapour, have shown an increase in inflammation markers such as IL-
6, IL-1α and IL-13, especially in the lung area (Lerner) and reduction in immune 
defence towards bacterial and viral infections as the phagocytosis by alveolar 
macrophages was compromised upon challenge with e-cigarette smoke (Sussan). In 
the case of rats (Golli), e-cigarettes with nicotine affected the body weight and energy 
intake, and alteration in the lipid profiling (though some effect was observed when 
nicotine was not present).  Nevertheless, with or without nicotine, the e-cigarettes 
depleted the hepatic glycogen producing hyperglycemia and affected the kidneys by 
altering the anti-oxidant response in both cases.  This implyies that the rest of the 
ingredients have toxicological effects on renal ducts (Golli, Golli). 
Research on e-cigarette toxicity is not very extensive as the market is relatively new.  
Nevertheless, the area is not free of controversy. Several studies have been carried 
out on human and animal cells, animal models, stem cells and there were also some 
short clinical trials, using vapours and smoke extract obtained from e-cigarette devices 
as well as the e-liquid refills (Lerner). There is an increasing amount of research 
dedicated to the toxicity of the contents of the e-cigarette refills, looking at the biological 
activity of nicotine, the vehicle and flavours. (Bahl, Farsalinos 2013, Lerner). Studies 
on human bronchial airway epithelial cells and human foetal lung fibroblast showed 
that exposure to different flavours of e-liquids (lerner) exhibited high levels of stress in 
the form of reactive oxidative species (ROS).  Furthermore, the cell morphology 
changed to enlarged cells, cell viability decreased and inflammatory markers were 
raised and responses occurred in neutrophils (lerner, lerner 2016, highman). 
Published research is trying to shed light on the hot topic of “are they toxic” and more 
and more studies are focusing on comparing e-cigarettes to tobacco cigarettes. In a 
study comparing both types of smokes on HaCat (non-cancerous human 
keratynocytes) and A549 found that pro-inflammatory cytokines and chemokines 
(PDGf-BB, basic FGF, IL-8, IL-12, IL-17, GM-CSF, IP-10, MCP-1, MIP-1β in both cells 
and IL-1rα, IL-10, G-CSF, IFN-γ, RANTES, TNF-α and VEGF in HaCat) were released 
upon exposure to e-liquids, with cell death more preponderant in the traditional tobacco 
smoke (cervellati). 
A great majority of the biological studies focus on the lung and cardiovascular 
functions, with the result that the morphology of the nasal epithelia is being overlooked. 
A study was conducted on this topic by collecting biopsies and fluids from the nasal 
passages from non-smokers, as well as cigarette and e-cigarette smokers (Martin Not 
in ref list?). The changes in the expression of mRNA of key genes were used to monitor 
the health of the cells and the metabolic pathways. The findings include a decrease in 
the expression of immune related genes for electronic and traditional cigarette 
smokers, and in some cases the response was stronger in e-cigarettes.  This indicates 
that this type of smoking changes the immune composition at the nasal mucosa. A 
review by Biyani focused on the area of otorhinolaryngology (Biyani) and looked at the 
implications of e-cigarettes in a paediatric clinic where 80% of adult smokers started 
smoking before age 18. Though they did not present any clinical trials to determine the 
effect of passive e-cigarette smoking, they described the problem of liquid poisoning.  
As young adults, they commence to smoke, believing e-cigarettes to be non-toxic. 
A decrease in cardiovascular function has been linked to the use of traditional 
cigarettes, with the main side effect being inflammation, thrombosis and oxidation of 
low-density lipoprotein that can affect the myocardial activity (Grana, Jasper, Molina). 
A clinical study sponsored by the Lorillard Tobacco Company, used human subjects 
to compare limited exposure to e-cigarettes to traditional cigarettes (Yan) (for 
standardisation, 1 refill of 16mg/mL providing 50 puffs vs 1 Marlboro® Gold King size 
with both yielding around 0.8mg, though in real subjects this might vary).  Unlimited 
exposure found the nicotine plasma level to be increased (with the traditional cigarette 
having higher concentrations and acting faster after 5 minutes).  In addition, the 
combination of propylene glycol with glycerine in the e-liquid helps to deliver more 
nicotine than propylene glycol alone. The mechanism for heart rate increase due to 
nicotine has been elucidated and ascribed to the activation of the sympathetic nervous 
system with release of norepinephrine and epinephrine upon exposure to nicotine 
(Cryer, Benowitz). As the traditional cigarette increased nicotine in plasma more and 
faster than the e-cigarette, the heart rate increased in correlation to the amount of 
nicotine in plasma (Yan). Though the e-cigarettes increased the nicotine content in 
plasma which affected the systolic and diastolic blood pressure and increase the heart 
rate, it did so much less than traditional cigarettes.  Other studies seem to validate the 
notion that switching from traditional cigarettes to e-cigarettes (and hopefully then 
quitting completely) will assist to lower the systolic blood pressure (Farsalinos 2016, 
emergency paper, Burbank).  However some of them found that the nicotine plasma 
level were equal in both e-cigarettes and traditional cigarettes (St Helen).  
More recently studies are using different systems to assess toxicity, such as a C. 
elegans model (panitz), in which refill components (nicotine, propylene glycol, 
flavourings) were tested.  Oxidative stress, growth and brood size were affected in the 
same way when tests were conducted with liquid and vapours. 
It is important to note that many of the studies arrive to the same conclusion regarding 
the biological activity, as well as the analytical composition.  Parallels are difficult to 
draw amongst the many different studies as the concentration of the dosing sample 
varies, as well the test as conditions (such as feeding media, time and type of 
exposure).  An excellent review published in ATLAS (Manupello) comments on the 
majority of the in vitro methods used (2D, 3D) and different types of assays to study 
toxicology, risk assessment, cell transformation and cell health assays and genomic 
analysis of tobacco products.  This could be extremely important when planning 
biological research. 
Marketing and metrics 
With a world-wide market reaching over £35 billion by 2025 (Hartung long) not much 
emphasis can be found on the marketing that e-cigarettes receive, but a presentation 
by Monks and Crawford (Texas Tech University Health Sciences Center, El Paso) 
obtained on the USA Environmental Protection Agency website (Monks), provides 
some interesting numbers. In the UK figures obtained from Action on Smoking and 
Health (ASH) showed that e-cigarette user numbers rose from 700,000 in 2012 to 2.1 
million by 2014 (Hartung). For 2014, in the USA, around 13.4% (2 million) teens smoke 
them.  This highlights the growing tendency of this habit. On the other hand, this teen 
population fell from 15.8% of tobacco smokers to 9.2% by the same year (Hartung 
long). As this overall population is under 18, and banning laws apply, more disguises 
(tic-tac boxes, juice bottles) are found for the e-cigarettes to be smoked. Calls related 
to e-cigarette poisoning in the state of Texas showed that 57% was related to children 
younger than 5 years old.  These were unintentional, with 96% of cases occurring in 
their houses.  Of these, 85% was from ingestion and 11% dermal. This is an important 
aspect as the marketing directed to adults is also affecting small children. E-cigarette 
marketing has been very aggressive, with many adverts containing a strong sexual 
content, or trying to relate to foods/diets or traditional cigarettes, as well as using 
celebrities.  For this reason the advertising expenses have increased from $6.4 million 
in 2011 to a staggering $112.9 million in 2014 (Monks). 
 
In this paper we screened the web for information on the composition and toxicity of e-
cigarettes, with an emphasis on the flavour activities and health profiles. We decided 
to compare some of the published results with our own studies. We purchased around 
18 samples of e-liquids and exposed the human bronchial cell line Beas2B to different 
concentrations of the e-liquids. We also analysed the content of these samples using 
LC-MSMS. We found our data to be in agreement with other published material. 
 
Materials and methods 
Materials. The following materials and chemicals were obtained from Thermo Fisher 
Scientific, Altrincham, Greater Manchester, UK: 0.25% Trypsin-EDTA (GIBCO), sterile 
phosphate buffered saline, acetonitrile optimal LCMS grade (ACN), ammonium acetate 
analytical grade, formic acid optimal LCMS grade. Lonza, Slough, Berkshire, UK: 
BEGM Single-Quot kit. Sigma-Aldrich, Dorset UK: 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyl-tetrazolium bromide (MTT), sterile phosphate saline buffer (sPBS), nicotine, 
propylene glycol, dimethyl sulfoxide (DMSO), chlorpromazine. Other supplies include 
ECACC, Porton Down, Salisbury, UK: Beas2B cell line (immortalised cells obtained 
from autopsy of normal human bronchial epithelia from non-cancerous patients) VWR 
West Sussex, UK: plastic ware. Anachem, Luton, UK: pipettes and pipette tips. 
Amazon UK: e-cigarette refills. Superdrug, Manchester, UK: Nicolite refills. Hichrom, 
Reading, Berkshire, UK: 0.2µm polypropylene syringe filters. 
Cell maintenance. Cells were grown as adherent monolayer culture in 75cm3 flasks in 
Bronchial Epithelial Growth Medium (BEGM) using Lonza’s BEGM SingleQuot kit, at 
37°C, and under a humidified atmosphere containing 5% CO2 and 95% air. Cells were 
changed twice a week after reaching 70% confluence. 
MTT assay. Two types of e-liquids are available on the market.  These are synthetic 
ones, containing artificial flavours and natural ones, containing extracts of tobacco 
leaves and natural flavours extracted from plants. Pre-packed cartridges can have 
varying nicotine concentrations (ranging between 0-18 mg/ml nicotine/cartridge) with 
diverse flavourings, for example tobacco, menthol, mint, chocolate, apple, cherry, 
caramel and many more (12,13). We used different suppliers that were commercially 
available over the counter and through the internet. We tested a variety of flavours and 
nicotine content, as well as synthetic nicotine and propylene glycol which is used 
generally as carriers for the production of the vapours. All e-cigarette refills, nicotine 
and propylene glycol were tested at a range of concentrations (0, 4, 10, 20, 40, 80, 
120, 160 and 200% puff, with each puff being 5 µl (100%) for e-cigarettes.  Dilutions 
were made up in sterile water from 0-1.64mg/ml for the nicotine stock solution, 0-
0.1g/ml for propylene glycol stock solution, and 0-100 µM for chlorpromazine stock 
solution (this is the positive control in all assays). Cell death percentage was 
determined by the colorimetric MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-
tetrazolium bromide] micro-culture assay. Cells were detached from the 75cm3 flasks 
(at a confluence of 70%) by trypsinisation, seeded in 100μl aliquots into 96-well clear 
micro-culture plates. Cell densities of 40,000; 30,000 and 20,000 cells/ml for 24, 48 
and 72 hours of incubation were used respectively.  This method was chosen in order 
to ensure exponential growth of untreated controls throughout the experiment. Cells 
were allowed to grow in the 96-well micro-culture plate for 24 hours prior to dosing. 
Stock solutions of the test compounds in water were appropriately diluted in complete 
culture media to make up the required concentrations, and then added in 10μL aliquots 
into the 96-well micro-culture plate.  Cells were exposed to the test compounds for 72 
hours. Plates were maintained at 37°C in a humidified atmosphere containing 95% air 
and 5% CO2. At the end of the incubation period, 30μl/well MTT solution in sPBS (3 
mg/ml) were added, then incubated for a further 3 hours. After the end of the 
incubation, the supernatants containing medium and MTT were removed and the 
formazan crystals formed by the viable cells were dissolved in 100μl of DMSO per well. 
Optical densities at λ = 540 nm were measured with LUMIistar Omega multi-mode 
plate reader (Edinburgh, UK). The colorimetric MTT assay was used to determine the 
cell death percentage at a serial diluted concentration of the tested compounds and 
the concentration at which 50% of cell growth was inhibited (IC50).  In comparison to 
the control wells which did not contain any test component, was determined from a 
dose–response curve using OriginPro 9.1 (Northampton, MA, USA) data analysis and 
graphing software. Chlorpromazine was used as positive control in the MTT assay. 
Data were collected as duplicates and statistical analysis calculated as standard 
deviation (SD) using Excel Microsoft (Reading, Berkshire, UK). Pictures were taken 
with a Axio Vert.A1, PE-300 microscope from Zeiss, Cambridge, Cambridgeshire, UK. 
Mass spectrometry. The analysis was performed on an Agilent 6540 LC-MSMS Q-ToF 
Jet Stream ESI (Greater Manchester, UK).  Measurement conditions were: +2500V, 
CE (collision energy) 80eV, Sheaf gas 350oC at 10l/min, drying gas at 325oC at 
10L/min. Nebuliser gas pressure was at 18psi. The chromatography was performed 
on an Agilent 1260 series (Greater Manchester, UK) with auto sampler and thermal 
controlled column chamber.  The separation was done on a Thermo Scientific 
Accucore HILIC 50x2.1mm particle size 2.6µm (Thermo Fisher Scientific, Altrincham, 
Greater Manchester, UK) column kept at a stable 20oC. The flow rate was set at 
0.4ml/min using a gradient profile of ACN (acetonitrile) 95%:H2O 5% (0.1% formic acid 
/ 5mM ammonium acetate) 0min: 100%. 20min: 60%. 25min 100% end 30min, with the 
remainder being H2O (0.1% formic acid / 5mM ammonium acetate). The column was 
prepared and stabilised for 6hours before running using ACN 95%:H2O 5% (0.1% 
formic acid / 5mM ammonium acetate) with a flow rate of 1.0 ml/min. The samples 
were prepared by diluting the e-cigarette fluid of 10µl with 990µl of ACN and filtering it 
through 0.2µm polypropylene syringe filters (this is known as “dilute and shot 
methodology”). 
Results and Discussions 
We tested 18 different e-cigarette refill flavours for their toxicity on human derived 
bronchial cells (Beas2B). In our studies we exposed the cells at different 
concentrations and times to the cells. The definition of “puff”, its volume and quantity 
seems to be different in various publications, as made with reference to the total 
reservoir and expressing it into nicotine content1,41-43. The puff is also dependent on 
the user, with some puffing a larger volume than others. Based on literature evidence 
of amount of nicotine used41-43 and the given value per cartridge of nicotine at an 
average of 18mg/ml, we calculated that 1 inhalation might be equal to 5µl, and this 
“puff” would contain around 90µg of nicotine.  
Biological data 
In this work we will equate 1 puff to 5µl of the e-liquid refill. The Beas2B were exposed 
to 0, 4, 10, 20, 40, 80, 120, 160 and 200% puffs. This in effect means 0, 0.2, 0.5, 1, 2, 
4, 6, 8, 10 µl of refill respectively (dilutions were made with distilled sterile water). 
Exposure periods were for 24, 48 and 72 hours. The bronchus conducts the air into 
the lungs where the surface area44 can varied in the range of 40-80m2. Although 1 puff 
(5µL) appears to be a large volume, smokers rarely would have only 1 puff. Instead 
there would be a continuous flow.  Therefore our aim is to study how it can affect the 
viability of the bronchial cells. 
In Table I, we show the IC50 values obtained from duplicate results. At 24 hours, the 
IC50 values ranged from 1.12 to 70%, making some e-cigarettes based on menthol, 
tobacco and butterscotch flavours the most toxic ones (Figure 1). The same pattern 
seems to be repeating itself at 48 and 72 hours with ranges between 6.3-40% and 1-
92% respectively. Propylene glycol seems to show more toxicity when the cells were 
exposed at longer times (48 and 72 hours), while nicotine was quite consistent through 
the total study. Flavours like grape, blueberry, cherry and some menthol blends 
produced the lowest toxicity. 
To have a clearer understanding of the results, we plotted the IC50 values (Figure 1). 
It is interesting to note that at 24 hours the majority of the samples tested are very toxic 
with the IC50 values in the lower 1/3 band on the y axis.  At 48 hours this tendency 
changes to be more in the middle band and at 72 hours there is a clear tendency for 
higher toxicity (lower band in the y axis). It is interesting to note the e-cigarettes 
flavoured with vanilla and grape are the less toxic samples. Icemint can be a complex 
mixture and this is observed in the increasing toxicity it showed on the cells. 
Pictures of each sample at dosages of 200, 120, 10, 4 and 0% puffs (a summary in 
Figure 2 and the remaining pictures and IC50 curves in the Appendix) were taken. In 
Figure 2, the pictures show the cells exposed to a low puff concentration (10% of puff) 
for the longest period of time (72 hours). 
In our set of 18 e-cigarette refill samples, we studied different fruit flavours as well as 
candy flavours such as butterscotch and bubblegum. The butterscotch flavour when 
inhaled has been found to be responsible for a particular lung condition in employees 
working in popcorn factories, called popcorn lung44.  Exposure to diacetyl in the 
butterscotch flavour in the working environment affects the middle and lower airways 
producing cough, dyspnea, and bronchiolitis obliterans (Maier). This flavour has been 
discontinued in the market of electronic cigarettes.  However, reports (Hartun short) 
express concerns as this is found in around 75% of all e-liquids samples.  Alternatives 
have been proposed (such as 2,3-pentadione, 2,3-hexanedione, 3,4-hexanedione and 
2,3-heptanedione) and studied on murine models.  Results indicate that they might not 
be completely safe (Anderson). The sample we obtained were shown to be very toxic, 
with IC50 values for 1, 2 and 3 days of exposure around the value of 10% of a puff 
(0.5µL). The pictures clearly show how cell numbers are low and the cells are very 
elongated when compared to cells exposed to the media only. The other candy flavour, 
bubblegum, though toxic, had IC50 values in the range of 20 to 30% of a puff, with cell 
numbers higher and displaying a slightly rounder shape. 
A popular flavour, vanilla, seems to be gaining territory in the market. In our testing of 
a sample of vanilla refill, we found the IC50 values to be moderately toxic at 24 and 48 
hours of exposure (~20%) and much less toxic at 72 hours (80%). This implies that the 
cells can recover with time if not exposed continuously. The cell numbers in the 
photographs (appendix) not only showed higher survival rates, but the cells were 
forming islands which is characteristic of lung type cells. Menthol and mint are very 
popular flavours, so we tested one sample of mint (icemint) and three samples of 
menthol. We found that the mint flavour was low in toxicity after 1 day of exposure (IC50 
= 70%), but became more toxic the longer the cells were exposed (IC50 in the range of 
30-20%). Furthermore, the cells also looked very unhealthy after the initial times of 
exposure, but showed remarkable recovery towards the 72 hour period of incubation.  
It is possible that the cells managed to metabolise the toxic contents to less damaging 
agents. The menthol samples were in general very toxic with IC50 values for all 
incubation times lower than 20%. The cells appeared elongated and in the majority of 
cases quite isolated.  It is interesting to notice that samples from different suppliers 
have different toxicity, giving rise to questions as to what the ingredients are or at least 
the percentages in those refills. 
Electronic cigarettes, as a relatively healthier option, have much less ingredients than 
a tobacco based cigarette. Nevertheless, because the tobacco flavoured e-cigarette is 
popular amongst consumers, we tested 4 samples of tobacco based e-cigarettes with 
different concentrations of nicotine. We found them all to be quite toxic.  For example, 
the classic tobacco flavour has IC50 values around 10%, and for tobacco with nicotine 
it was around 10-30% in a sample of virgin tobacco. It also became very toxic the 
longer the cells were exposed to the liquid. The cells looked much damaged at high 
concentrations and short exposure times, showing a very flat and elongated 
appearance towards the end of the experiment. 
Fruit based flavours are very popular with younger generations. Suppliers might use 
natural or synthetic flavours to produce the desired flavour. From all the samples 
tested, except Dekang Cherry Blossom, they did not have nicotine in the ingredients 
list.  This could explain why in general these samples were less toxic. We tested refill 
flavours of banana, blueberry, grape, apple, strawberry and cherry. We found them to 
be moderately toxic (IC50 values in the vicinity of 30%), with the grape flavour being 
the least toxic one. Nevertheless, at high concentrations of refill liquid and short 
exposure times the cells look disperse, elongated and damaged. Towards the end of 
the trial, the cells looked healthier and formed some islands, thus showing better 
recovery. 
We tested stock solutions of nicotine and the propylene glycol carrier control. We found 
nicotine to be moderately toxic in the range of what it would be expected to appear in 
puffs (IC50 values between 15-30%). We also found that propylene glycol became 
increasingly toxic the higher the volumes of the puff and the longer the exposure times 
were (IC50 values between 5-15%). In both cases cells looked unhealthy with a 
tendency to recover. 
Interestingly, in a study performed on HaCat (normal human immortal keratinocytes), 
HN30 (human neck squamous cell carcinoma from a primary laryngeal tumour) and 
UMSCC10B (human neck squamous cell carcinoma from a metastatic lymph node) for 
which vapour of e-cigarettes with and without nicotine were tested, found a ~1.5 fold 
for samples without nicotine and up to 3 folds for samples with nicotine increased cell 
death when the DNA strand breaks were tested (Yun). Extrapolating the results from 
in vitro to in vivo does not seem to be an easy subject, as there are many variabilities 
in the e-cigarette delivery due to different electronic devices.  Some research points in 
the direction of the nicotyrine hypotheses (Abramovitz). This chemical, a product of the 
oxidation of nicotine, seems to accumulate in e-liquids with time when it is exposed to 
air.  It is a reversible inhibitor for CYP2A13 in the nasal and respiratory epithelia, and 
irreversible inhibitor of CYP2A6 in the liver. The hypothesis postulates that nicotine is 
delivered more effectively if nicotyrine is present because it facilitates the absorption 
in the airway epithelia (by inhibiting CYP2A13) and inhibites nicotine’s metabolism in 
the liver (by inhibiting CYP2A6).  It therefore raises the nicotine’s plasma concentration 
and hence relieve the nicotine craving (Abramovitz). Though data seems to support it, 
more evidence needs to be acquired. 
Analytical data 
We studied the 18 samples for their composition as well as nicotine content. Using 
state-of-the-art mass spectrometry equipment, we developed new liquid-
chromatography methodologies to test the ingredients and analyse the content of the 
main toxicant. An Accucore HILIC column was employed, and in it, nicotine showed a 
retention time of 7.55min.  The sample was measured using MS/MS fragmentation 
163.1230m/z → 131.0650 m/z with CE of 30eV.  A dilution curve with a highest amount 
of 25 mg/ml was prepared to quantify the areas related to the nicotine content. The 
results (Figure 3) showed that the samples which according to the manufacturer’s 
labels should be nicotine free, had quantifiable levels of nicotine within them.  The 
majority of them had extremely low amounts in the low ppm level (part per million), 
though some such as butterscotch had 0.015% and juicy apple 0.03%. On the other 
hand, the levels of nicotine in samples which have stated nicotine contents (according 
to the manufacturer’s labels), vary depending upon the producer. The Nicolite brand, 
showed a large variation in the analysed to stated amounts, e.g the 11mg/ml sample 
showed values close to 9mg/ml.  The 16 mg/ml samples that had different flavours 
such as tobacco and menthol, ranged from approximately 6mg/ml to almost 12 mg/ml. 
The other manufacturers, Dekang and Vapouriz, for which the labels described a 
content of 18 mg/ml, varied in the range of 16 mg/ml to 18 mg/ml. The levels of nicotine 
are likely indicators that GMP (good manufacturing practices) is not being followed by 
some manufactures of the e-cigarette fluids, and may run afoul of the current 
manufacturing guide lines set by the European Union45.  It is interesting to notice that 
nicotine based e-cigarette refills showed the highest toxicity with IC50 values ranging 
from 3 to 25 % puff for the 72 hours period of incubation on the Beas2B cells. 
One of the most concerning flavour ingredient in e-fluids is the butterscotch flavouring, 
i.e diacetyl flavouring (butane-2,3-dione, also a diketone), (1.2min retention time)) 
which is known to produce lung disease when inhaled44,46. We analysed the AV 
Butterscotch flavour e-cigarette refills, and we found the content of diacetyl (presented 
at a retention time of 1.2min) was 10625 molecular count which in real terms means 
traces. This comes as good news for e-cigarette smokers, as other flavourings can be 
used to mimic the butterscotch flavour or aroma. Nevertheless in this particular e-
cigarette refill sample, the biological data showed high toxicity in the biological 
assessment, implying that the flavouring agent, maybe another member of the 
diketones family, is also toxic47.  
Tobacco flavours are extremely popular as it might give the e-cigarette smoker the 
sensation of a real cigarette, but without the toxins. We investigated four samples of 
refills containing tobacco flavour and we found (Figure 5, the results are presented as 
molecular counts and they are actually traces in the low ppm of flavours only) they 
contain traces of several other chemicals, including flavouring agents such as vanillin, 
ethyl butyrate (tropical flavour), ethyl vanillin, ethyl-methyl-maleimide (tobacco), β-
damascone (fruit), butanedione (butter) and benzyl alcohol (fruit). Investigation of the 
flavour profile of the tobacco flavoured e-fluids showed that it is possible to “fingerprint” 
the different manufacturer batches. While the number investigated was small it does 
open up the possibility of a data base for forensic analysis of e-cigarette analysis. 
Overall we found the e-cigarette refills contain around 99% of the carrier, with this being 
generally propylene glycol, up to 0.8% of nicotine (near 0% in the free nicotine refills), 
0.018% sweetener (in the form of maltol / ethyl maltol and other sweetening flavours) 
and 0.002% of flavouring agents, including unknowns. It is this 0.002% that would help 
to fingerprint a sample. Our data is in good agreement with other studies (Tayyarah) 
that have reported e-cigarette liquid to contain glycerol or propylene glycol ≥75%, water 
≤18%, nicotine ~2% and flavours ~10%. All the tobacco samples proved to be highly 
toxic with the Vapouriz ones presenting the highest cell death rate.  Incidentally, they 
have less ethyl-methyl-maleimide though they have higher levels of vanillin based 
flavour. The small difference in the tobacco samples for the IC50 could be due to 
unknown ingredients in the refill, as many times manufacturers use natural or complex 
extras. 
Conclusion 
Research by Action on Smoking and Health (ASH) showed e-cigarettes users has 
rapidly increased48 with the teenage group increasing 800% (Kaisar).  E-cigarettes are 
considered as one of the options helping people to quit smoking. However, the safety 
and reliability of e-cigarettes have to be reviewed extensively. Many of the literature 
reports reviewed, indicate that e-cigarettes are not free of emissions13,14,16, as they 
release an aerosol containing acetaldehyde, formaldehyde, nicotine, propylene glycol, 
glycerol and flavourings.  Users and those who are exposed to second-hand inhalation 
can be affected16,36. Our work supports the opinion that e-cigarettes and especially the 
ingredients of the e-liquid, which can change in structure after the process of heating, 
have not been thoroughly characterised or evaluated for safety37. The evaluation of the 
results of this investigation supports our hypothesis that certain flavours of e-liquids, 
like menthol, tobacco and coffee are more toxic than others such as banana or apple, 
which show less toxicity on Beas2B cells by direct liquid exposure.  
In a previous study the cytotoxicity of e-cigarette refill samples using human embryonic 
and adult cells, showed that majority of samples were moderately to highly toxic to the 
embryonic cells, but less toxic on the adult cells. Also, the cytotoxicity was correlated 
to the other components of the fluids rather than the presence of nicotine37. In another 
study, the cytotoxicity of liquid (smoke) flavourings was assessed and compared with 
that of cigarette smoke condensate. It was found that the cigarette smoke condensates 
were generally less toxic than liquid smoke flavourings on Chinese Hamster Ovary 
cells (CHO)38. Published results have shown in in vitro studies that human bronchial 
cells exposed to different e-cigarette vapours had mutations in the gene patterns, 
similar to exposure to tobacco smoke49.  
The existing research does not indicate that e-cigarettes are completely safe, even 
though the delivery of nicotine without the toxins found in tobacco cigarettes makes 
them a safer option. E-cigarette vaping is less toxic than smoking normal cigarettes, 
and this group of users benefit from this new technology. Nevertheless, e-cigarettes 
contain toxicants, including nicotine, flavourings and volatile compounds, and their 
thermal degradation products.   
We have clearly shown that flavours such as menthol, tobacco, and butterscotch can 
be considered toxic. However, the assumption that e-liquids with nicotine, especially 
with higher concentrations of 16 mg/ml plus, could be more toxic than the one without 
nicotine, could not be proven. Nevertheless, e-liquids such as blueberry and tobacco 
are more toxic with a lower IC50-value then e-liquids with nicotine.  
Public Health England (PHE) has endorsed the use of e-cigarettes to help smokers to 
quit the habit (McNeil).  Evidence seems to indicate that smoking electronic cigarettes 
is healthier than traditional tobacco cigarettes, so for the traditional cigarette smoker 
this is a good option, especially if it allows overall quitting. However, concerns have 
been raised for the passive smoker and the younger generations who find smoking e-
cigarettes an exciting new habit (Monks, McKee). Politics, policies and funding seem 
to play an important role in the evaluation of the safety of e-cigarettes. Therefore, more 
independent, long-term research needs to be conducted to determine how safe e-
cigarettes really are (McKee). 
The work reported in this paper further contributes useful and new information to 
debate on the safety of e-cigarettes and the different flavouring liquids consumed by 
users in the devices, and clearly indicate some areas of concern which warrant closer 
attention in future.  This in agreement with a recent clinical trial in where several 
toxicants biomarkers (nicotine and metabolites) from both traditional and e-cigarettes 
were monitored and shown the exposure was reduced upon switching.Reference? 
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Table I: IC50 values of different e-cigarette refills tested on Beas2B at 24, 48 and 72 
hours. (Results for duplicate determinations). *: these samples do not contain nicotine. 
1: (IC50 in µM, ± SD) 
IC50 (% of puffs, ± SD) 24 hours 48 hours 72 hours 
Aulola Butterscotch* 7.4 ± 5.2 10.1 ± 3.6 9.2 ± 1.7 
Vapouriz Bubblegum* 28.3 ± 0.6 26.3 ± 10.5 17.1 ± 2.1 
Vapouriz Vanilla Velvet* 25.5 ± 1.6 19.3 ± 0.9 79.0 ± 0.3 
Vapouriz Banana* 12.5 ± 1.7 39.8 ± 0.4 26.0 ± 0.9 
Vapouriz Grape* 32.7 ± 5.8 29.7 ± 9.7 91.6 ± 0.2 
Dekang CherryBlossom18mg/ml 20.9 ± 4.0 22.8 ± 1.8 24.7 ± 0.8 
Vapouriz Blueberry* 28.5 ± 1.8 12.3 ± 3.8 30.1 ± 8.8 
Dekang Blueberry Mist* 37.6 ± 0.1 24.5 ± 0.1 21.0 ± 1.1 
Vapouriz Strawberry Bliss* 20.8 ± 0.3 17.3 ± 0.1 18.2 ± 0.6 
Vapouriz Juicy Apple* 29.8 ± 6.3 21.5 ± 3.5 28.7 ± 0.6 
Nicolite Menthol 16mg/ml 8.7 ± 0.9 6.3 ± 2.6 2.8 ± 14.4 
Dekang Menthol 18mg/ml 21.7 ± 0.6 10.8 ± 2.4 12.3 ± 1.2 
Vapouriz Menthol Special blend 1.1 ± 1.6 18.4 ± 1.7 22.2 ± 4.1 
Vapouriz Icemint 68.9 ± 0.1 32.9 ± 0.9 19.3 ± 0.8 
Vapouriz Classic Tobacco 4.3 ± 7.3 9.5 ± 3.9 11.9 ± 6.5 
Vapouriz Virgin Tobacco 30.9 ± 5.8 15.2 ± 0.8 <1 ± 2.19 
Nicolite Tobacco 11mg/ml 21.9 ± 1.2 36.9 ± 0.3 11.5 ± 2.5 
Nicolite Tobacco 16mg/ml 31.0 ± 3.2 11.9 ± 14.7 24.7 ± 7.6 
Nicotine stock 18mg/ml 32.3 ± 1.5 27.2 ± 1.8 13.9 ± 2.9 
Propylene glycol stock 1g/ml 14.7 ± 5.4 9.5 ± 19.2 5.7 ± 2.2 
Chlorpromazine 1 3.1 ± 9.0 1.5 ± 4. 7 1.0 ± 0.2 
 
 
Figure 1: IC50 values at 24, 48 and 72 hours. 
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 Figure 2: Cells exposed to 10% (0.1) puff for 72 hours: a: Aureola Butterscotch, b: 
Vapouriz Banana, c: Dekang Blueberry Mist, d: Vapouriz Juicy Apple, e: Vapouriz 
Bubblegum, f: Vapouriz Grape, g: Vapouriz Strawberry Bliss, h: Nicolite Menthol 
16mg/ml, i: Vapouriz Vanilla Velvet, j: Dekang Cherry Blossom, k: Vapouriz Blueberry, 
l: Dekang Menthol, m: Nicolite Tobacco 16 mg/ml, n: Vapouriz Virgin Tobacco, o: 
Nicolite Tobacco 11mg/ml, p: Vapouriz Classic Tobacco, q: Vapouriz Icemint, r: 
Vapouriz Menthol Special Blend, s: Nicotine stock (pharmaceutical grade) 
(0.08mg/ml), t: Propylene Glycol stock (0.005g/ml), u: Media 
 Figure 3: Analytical determination of nicotine in the e-cigarette refills for which the 
nicotine content is 0 (zero) according to the package information. 
 
Figure 4: Analytical determination of nicotine in the e-cigarette refills for which the 
nicotine content varies from 11 mg/ml to 18 mg/ml according to the package 
information. 
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 Figure 5: Analytical determination and fingerprint analysis of tobacco flavour in the e-
cigarette refills. 
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